Cargando…
Automated synthesis of prexasertib and derivatives enabled by continuous-flow solid-phase synthesis
Recent advances in end-to-end continuous-flow synthesis are rapidly expanding the capabilities of automated customized syntheses of small-molecule pharmacophores, resulting in considerable industrial and societal impacts; however, many hurdles persist that limit the number of sequential steps that c...
Autores principales: | Liu, Chenguang, Xie, Jiaxun, Wu, Wenbin, Wang, Mu, Chen, Weihao, Idres, Shabana Binte, Rong, Jiawei, Deng, Lih-Wen, Khan, Saif A., Wu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054510/ https://www.ncbi.nlm.nih.gov/pubmed/33875818 http://dx.doi.org/10.1038/s41557-021-00662-w |
Ejemplares similares
-
Dose‐finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors
por: Iwasa, Satoru, et al.
Publicado: (2018) -
Continuous-Flow Synthesis of Thioureas, Enabled by Aqueous Polysulfide Solution
por: Németh, András Gy., et al.
Publicado: (2021) -
Automated Solid Phase Oligosaccharide Synthesis
por: Castagner, Bastien, et al.
Publicado: (2007) -
EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
por: Lee, Kevin J., et al.
Publicado: (2020) -
Continuous Flow Processes
as an Enabling Tool for
the Synthesis of Constrained Pseudopeptidic Macrocycles
por: Esteve, Ferran, et al.
Publicado: (2022)